"Mesalamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
| Descriptor ID |
D019804
|
| MeSH Number(s) |
D02.241.223.100.050.300.500 D02.241.223.100.300.595.100.540 D02.241.511.390.595.100.540 D02.455.426.559.389.127.020.452.750 D02.455.426.559.389.127.281.595.100.540 D02.455.426.559.389.657.410.595.100.540
|
| Concept/Terms |
Mesalamine- Mesalamine
- Mesalazine
- m-Aminosalicylic Acid
- m Aminosalicylic Acid
- 5-Aminosalicylic Acid
- 5 Aminosalicylic Acid
- meta-Aminosalicylic Acid
- meta Aminosalicylic Acid
|
Below are MeSH descriptors whose meaning is more general than "Mesalamine".
Below are MeSH descriptors whose meaning is more specific than "Mesalamine".
This graph shows the total number of publications written about "Mesalamine" by people in this website by year, and whether "Mesalamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesalamine" by people in Profiles.
-
Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea. Neurogastroenterol Motil. 2024 Oct; 36(10):e14889.
-
Low-dose aspirin and mesalazine for patients with familial adenomatous polyposis. Lancet Gastroenterol Hepatol. 2021 06; 6(6):418-419.
-
Mesalazine allergy in a boy with ulcerative colitis: clinical usefulness of mucosal biopsy criteria. Clin J Gastroenterol. 2016 Oct; 9(5):302-5.
-
Frequency and associated factors of hair loss among patients with inflammatory bowel disease. World J Gastroenterol. 2015 Jan 07; 21(1):229-32.
-
Inflammatory bowel disease characteristics in Hispanic children in Texas. Inflamm Bowel Dis. 2012 Mar; 18(3):546-54.
-
On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease. Nitric Oxide. 2010 Feb 15; 22(2):155-67.
-
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis. 2004 Jan; 10(1):1-14.
-
Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease. Am J Gastroenterol. 2001 Aug; 96(8):2520-2.
-
Disposition of olsalazine and metabolites in breast milk. J Clin Pharmacol. 1993 Aug; 33(8):703-6.
-
IBD: which 5-ASA drug works where? J Pediatr Gastroenterol Nutr. 1993 May; 16(4):474-5.